UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example MedicinalProductDefinition: Xyloproct-RectalOintment-SE-AJ-MPD

Generated Narrative: MedicinalProductDefinition Xyloproct-RectalOintment-SE-AJ-MPD

identifier: http://ema.europa.eu/fhir/mpId/SE-100001718-00008340, http://ema.europa.eu/fhir/eurdId/1679

domain: Human use

status: Current

combinedPharmaceuticalDoseForm: Rectal ointment

indication:

Xyloproct rektalsalva och Xyloproct suppositorier är avsedda för behandling av vuxna. Behandling av hemorrojder, analtenesmer och analfissurer samt postoperativt efter anorektala ingrepp eller i samband med anorektala explorationer. För egenvård: hemorrojder och ytliga ändtarmsirritationer.

legalStatusOfSupply: Medicinal product not subject to medical prescription

classification: hydrocortisone

name

productName: Xyloproct Rektalsalva

part

part: Xyloproct

type: Invented Name Part

part

part: Rektalsalva

type: Pharmaceutical dose form part

Usages

-CountryLanguage
*Kingdom of SwedenSwedish